Novo Nordisk rebrands to 'Novo,' CEO tells CNBC drugmaker needs to 'rethink' strategy amid obesity race
The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly.
Read it at CNBC See this on the map
What might happen next? AI-generated
These scenarios are written by an AI language model from the headline and summary above. They are not predictions from the newsroom, and they are not evidence of anything. Every one is given a deadline and checked against later coverage, and the score is published on the ledger — including the ones that miss.
ForecastGeo shows the headline and summary published by the newsroom and places the story on a map. The full article lives at the source.